Status:
TERMINATED
Post-op Treatment With Hyaluronic Acid Injections
Lead Sponsor:
The Hawkins Foundation
Collaborating Sponsors:
Ferring Pharmaceuticals
Conditions:
Meniscus Tear
Chondropathy/Degenerative Joint Disease (DJD)
Eligibility:
All Genders
40+ years
Phase:
NA
Brief Summary
This study will look at patients with post-operative treatment of a meniscal tear or degenerative joint disease (degenerative arthritis). They will be randomized into one of three groups: Euflexxa inj...
Eligibility Criteria
Inclusion
- Patients in post-op stage of treatment for meniscal tears or chondropathy/DJD
- Over 40 years of age
- A daily knee pain above 20mm on a 100mm visual analogue scale
Exclusion
- Previous recipient of viscosupplementation injections
- Had rheumatoid arthritis or other inflammatory arthritis
- Had intra-articular steroid injections within the previous 2 months
- Invasive knee procedures within the past 6 months
- Contraindications to hyaluronate (an allergy)
- Medications that could interfere with the planned interventions
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2014
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT01256788
Start Date
September 1 2010
End Date
April 1 2014
Last Update
January 8 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Steadman Hawkins Clinic of the Carolinas
Greenville, South Carolina, United States, 29615